Veterinary Infusion Pumps Market: Growing Adoption of Companion Animals
Factors such as the growing demand for pet insurance and increasing animal healthcare expenditure,
rising demand for animal-derived food products, and growth in the number of veterinary practitioners
and their income levels are the primary growth drivers for U.S. veterinary infusion pumps market.
To know about the assumptions considered for the study, download the pdf brochure @
Growing adoption of companion animals and increasing prevalence of animal diseases requiring
surgeries are expected to offer significant growth opportunities to market players in the coming years.
However, increasing pet care costs may hinder the growth of this market to a certain extent.
The veterinary infusion pumps market is estimated to grow at a CAGR of 5.8% from 2016 to 2021, to
reach USD 35.4 Million by 2021.
On the basis of type, the market is segmented into large-volume infusion pumps and syringe infusion
pumps. In 2015, the large-volume infusion pumps segment accounted for the largest market share,
primarily due to the increasing use of these pumps for delivering large volumes of fluids to animals
during emergency conditions, providing blood transfusions, and administering total parenteral nutrition
at continuous predetermined medium-to-high flow rates.
Request a Sample Pages @
Based on end user, the market is segmented into private hospitals, private clinics, and teaching
hospitals. Private hospitals are expected to dominate this market in 2015.
The U.S. veterinary infusion pumps market is characterized by the presence of a large number of
players. The market is dominated by DRE Veterinary (U.S.) and Jorgensen Laboratories (U.S.). Other
players operating in this market are Heska Corporation (U.S.), Digicare Biomedical Technology Inc. (U.S.),
B. Braun Melsungen AG (Germany), Q Core Medical Ltd. (Israel)